Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Magellan Health	MEDNAX	Medical Facilities	Animalcare Group	Spine Injury Solutions
Symbol	NASDAQ:MGLN	NYSE:MD	TSE:DR	LON:ANCR	OTCMKTS:SPIN
Price Information
Current Price	$94.32	$29.74	C$8.30	GBX 337.70	$0.30
50-Day Moving Average	$94.32	$30.59	C$7.40	GBX 325.88	$0.26
52-Week Low	$69.35	$12.47	C$3.75	GBX 150	$0.03
52-Week High	$95.43	$34.19	C$8.40	GBX 366	$0.43
MarketRank™
Overall Score	2.2	1.4	1.7	1.4	1.2
Analysis Score	1.2	0.9	2.4	0.0	0.0
Community Score	4.3	4.3	4.1	4.7	4.5
Dividend Score	0.0	0.0	0.8	1.7	0.0
Ownership Score	2.5	0.0	0.0	0.8	1.7
Earnings & Valuation Score	3.1	1.9	1.3	0.0	0.0
Analyst Ratings
Consensus Recommendation	Hold	Hold	Buy	N/A	N/A
Consensus Price Target	$93.33	$23.83	C$9.17	N/A	N/A
% Upside from Price Target	-1.05% downside	-19.86% downside	10.44% upside	N/A	N/A
Trade Information
Market Cap	$2.47 billion	$2.57 billion	C$258.18 million	£202.93 million	N/A
Beta	1.21	2.17	N/A	N/A	N/A
Average Volume	175,018	436,243	61,183	74,893	N/A
Sales & Book Value
Annual Revenue	$4.58 billion	$1.73 billion	C$365.09 million	£70.49 million	$170,000.00
Price / Sales	0.54	1.48	0.71	2.88	N/A
Cashflow	$5.56 per share	$1.16 per share	C$1.88 per share	GBX 9.35 per share	N/A
Price / Cash	16.95	25.72	4.42	36.14	N/A
Book Value	$73.03 per share	$8.74 per share	C$4.16 per share	GBX 135.90 per share	($0.01) per share
Price / Book	1.29	3.40	2.00	0.02	N/A
Profitability
Net Income	$382.33 million	$-796,490,000.00	N/A	N/A	$-300,000.00
EPS	$0.77	$0.76	C$0.15	GBX 0.40	N/A
Trailing P/E Ratio	6.19	N/A	55.70	844.25	0.00
Forward P/E Ratio	22.40	19.31	∞	∞	∞
P/E Growth	N/A	1.47	0.68	N/A	N/A
Net Margins	8.49%	-41.46%	N/A	N/A	-223.58%
Return on Equity (ROE)	2.84%	10.90%	N/A	N/A	N/A
Return on Assets (ROA)	1.47%	2.71%	N/A	N/A	-114.35%
Dividend
Annual Payout	N/A	N/A	C$0.21	GBX 0.02	N/A
Dividend Yield	N/A	N/A	2.58%	0.01%	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	143.56%	5.00%	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.28%	1.30%	84.11%	23.14%	N/A
Current Ratio	3.06%	2.04%	1.46%	1.54%	0.15%
Quick Ratio	2.99%	2.04%	1.28%	0.86%	0.35%
Ownership Information
Institutional Ownership Percentage	96.53%	N/A	N/A	N/A	N/A
Insider Ownership Percentage	14.10%	2.80%	N/A	N/A	42.79%
Miscellaneous
Employees	9,500	5,600	1,833	211	1
Shares Outstanding	26.15 million	86.28 million	31.11 million	60.09 million	N/A
Next Earnings Date	8/4/2021 (Estimated)	8/6/2021 (Confirmed)	8/12/2021 (Estimated)	9/28/2021 (Estimated)	11/12/2021 (Estimated)
Optionable	Optionable	Optionable	Not Optionable	Not Optionable	Not Optionable

Source	Headline
	Jets lineman Cameron Clark in hospital with neck injury myhighplains.com - August 3 at 6:19 PM
	Interspinous Process Decompression Devices Market – Increasing incidence of spinal injuries is also expected to boost growth of market medgadget.com - July 30 at 10:21 PM
	‘We don’t deserve this’: new app places US caregivers under digital surveillance theguardian.com - July 28 at 8:30 AM
	Urinary Catheters Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth openpr.com - July 27 at 10:10 PM
	Modern technology helps local man walk again news10.com - July 22 at 8:49 PM
	VA Palo Alto Receives New iBot Personal Mobility Device for Spinal Cord Injury Center finance.yahoo.com - July 22 at 5:48 AM
	Airlines keep losing and damaging wheelchairs at an alarming rate yahoo.com - July 21 at 5:36 PM
	Endoscopic Spinal Surgery Market is expected to exhibit a CAGR of over 8% through the forecast period (2021 - 2031) : P&S Persistence markets.businessinsider.com - July 16 at 9:25 AM
	Endoscopic Spinal Surgery Market is expected to exhibit a CAGR of over 8% through the forecast period (2021 - 2031) :Persistence Market Research wfmz.com - July 16 at 9:25 AM
	Ear wands, nerve machines and 'pussy mist': I asked medical experts whether I should buy the miracle cures I see in my Instagram ads businessinsider.com.au - July 15 at 11:52 PM
	NervGen Pharma Establishes Multiple Sclerosis Clinical Advisory Board ca.finance.yahoo.com - July 15 at 8:51 AM
	Man arrested for notable DWI is local doctor eagletribune.com - July 14 at 6:34 PM
	Short Interest in Spine Injury Solutions, Inc. (OTCMKTS:SPIN) Declines By 93.4% americanbankingnews.com - July 14 at 8:18 AM
	VA Hospital Receives High-Tech Wheelchair That Can Climb Stairs patch.com - July 13 at 9:10 PM
	Pikes Peak region fitness coach recommends never skipping this one step gazette.com - July 12 at 11:26 PM
	Tennessee Chiropractor Shares What It Takes to Run A Successful Practice benzinga.com - July 7 at 7:48 AM
	Colorado Springs fitness coach has 1 step to never skip gazette.com - July 6 at 8:10 PM
	Patient advocacy groups and innovators must partner to advance new treatments statnews.com - July 6 at 8:10 PM
	Colorado Springs fitness coach wants to spread the message: Stretching is important gazette.com - July 6 at 10:07 AM
	Santa Ana CA Car Accident Injury Chiropractic Care/Pain Relief Treatments Launch asiaone.com - July 1 at 9:15 AM
	Heat wave prompts unusual demand to retrofit buildings with air conditioning bc.ctvnews.ca - June 30 at 11:59 PM
	LOOK: Manila introduces robotic-aids for physical therapy newsinfo.inquirer.net - June 30 at 7:50 AM
	First Choice Chiropractic Highlights the Common Back Pain Relief Techniques benzinga.com - June 30 at 7:50 AM
	Port of Tauranga contractors 'broken' after suffering serious back injuries from driving heavy machinery msn.com - June 30 at 2:47 AM
	Bridgeport Nonprofit Unveils New Apartments To Help Address Housing Insecurity wnpr.org - June 30 at 2:47 AM

Date	Company	Brokerage	Action
6/22/2021	MEDNAX	Stifel Nicolaus	Initiated Coverage
5/14/2021	Medical Facilities	National Bank Financial	Boost Price Target
5/14/2021	Medical Facilities	National Bankshares	Boost Price Target
5/14/2021	Medical Facilities	Royal Bank of Canada	Boost Price Target
5/10/2021	MEDNAX	Deutsche Bank Aktiengesellschaft	Boost Price Target
5/10/2021	MEDNAX	Mizuho	Boost Price Target
4/14/2021	MEDNAX	Truist	Boost Price Target
3/15/2021	Medical Facilities	Royal Bank of Canada	Boost Price Target
3/12/2021	Medical Facilities	Leede Jones Gab	Reiterated Rating
2/25/2021	MEDNAX	Credit Suisse Group	Lower Price Target
2/19/2021	MEDNAX	Citigroup	Lower Price Target
2/19/2021	MEDNAX	Deutsche Bank Aktiengesellschaft	Boost Price Target
1/15/2021	Magellan Health	Jefferies Financial Group	Downgrade
1/6/2021	Magellan Health	Stephens	Downgrade
1/5/2021	MEDNAX	Truist	Boost Price Target
12/11/2020	Medical Facilities	National Bank Financial	Boost Price Target
11/13/2020	Magellan Health	Stephens	Upgrade
11/13/2020	Medical Facilities	Royal Bank of Canada	Boost Price Target
11/13/2020	Medical Facilities	National Bank Financial	Upgrade
11/9/2020	Medical Facilities	National Bank Financial	Boost Price Target
11/3/2020	Medical Facilities	National Bank Financial	Boost Price Target
10/19/2020	MEDNAX	Deutsche Bank Aktiengesellschaft	Downgrade
10/6/2020	MEDNAX	UBS Group	Boost Price Target
9/10/2020	Magellan Health	Bank of America	Boost Price Target
8/17/2020	Medical Facilities	Royal Bank of Canada	Boost Price Target
8/17/2020	Medical Facilities	National Bank Financial	Boost Price Target
7/30/2020	Magellan Health	Jefferies Financial Group	Boost Price Target
6/8/2020	MEDNAX	BMO Capital Markets	Boost Price Target
6/8/2020	MEDNAX	Credit Suisse Group	Boost Price Target
5/29/2020	MEDNAX	Mizuho	Lower Price Target
5/21/2020	MEDNAX	SunTrust Banks	Boost Price Target
5/11/2020	MEDNAX	Cfra	Lower Price Target
5/11/2020	MEDNAX	Credit Suisse Group	Lower Price Target
5/8/2020	MEDNAX	UBS Group	Lower Price Target
5/8/2020	MEDNAX	Deutsche Bank Aktiengesellschaft	Lower Price Target
4/21/2020	MEDNAX	Robert W. Baird	Lower Price Target
4/13/2020	MEDNAX	SunTrust Banks	Lower Price Target
4/7/2020	Medical Facilities	National Bank Financial	Lower Price Target
3/26/2020	MEDNAX	Credit Suisse Group	Lower Price Target
3/13/2020	Medical Facilities	Echelon Wealth Partners	Upgrade
3/13/2020	Medical Facilities	Royal Bank of Canada	Lower Price Target
3/5/2020	Medical Facilities	National Bank Financial	Lower Price Target
3/3/2020	MEDNAX	Robert W. Baird	Lower Price Target
2/24/2020	MEDNAX	JPMorgan Chase & Co.	Lower Price Target
2/24/2020	MEDNAX	Credit Suisse Group	Lower Price Target
2/21/2020	MEDNAX	Citigroup	Lower Price Target
2/12/2020	Medical Facilities	Royal Bank of Canada	Upgrade
11/11/2019	Magellan Health	Stephens	Reiterated Rating
11/11/2019	Medical Facilities	National Bank Financial	Lower Price Target
11/8/2019	Medical Facilities	Royal Bank of Canada	Downgrade
11/5/2019	Medical Facilities	National Bank Financial	Lower Price Target
8/9/2019	Medical Facilities	National Bank Financial	Lower Price Target
8/9/2019	Medical Facilities	TD Securities	Downgrade
8/9/2019	Medical Facilities	Royal Bank of Canada	Lower Price Target
5/10/2019	Medical Facilities	Echelon Wealth Partners	Downgrade
5/10/2019	Medical Facilities	National Bank Financial	Lower Price Target
2/22/2019	Magellan Health	Bank of America	Initiated Coverage
1/14/2019	Magellan Health	Stephens	Initiated Coverage
11/13/2018	Magellan Health	SVB Leerink	Downgrade
11/12/2018	Magellan Health	Raymond James	Lower Price Target

(Data available from 8/4/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources